BioSpace News Archive

Daiichi Sankyo will present new clinical research across its oncology portfolio at the 2023 American Society of Clinical Oncology Scientific Program and the European Hematology Association Congress.

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced updated data from Part A of the ongoing registration-directed RAMP 201 trial evaluating the safety and efficacy of avutometinib alone and in combination with defactinib among patients with recurrent low-grade serous ovarian cancer.

Deciphera Pharmaceuticals, Inc. announced four poster presentations at the upcoming 2023 American Society of Clinical Oncology Annual Meeting, being held in Chicago, Illinois on June 2-6, 2023.

Shattuck Labs, Inc. announced the presentation of complete dose-escalation data from the Phase 1A monotherapy clinical trial of SL-172154 in PROC.

Veracyte, Inc. announced that new data to be shared at the 2023 American Society of Clinical Oncology Annual Meeting demonstrate the ability of the company’s Decipher Genomics Resource for Intelligent Discovery database to enable novel molecular insights into prostate cancer.

Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (“FY23”) ended March 31, 2023.

Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced oral and poster presentations during the upcoming Chemical Computing Group meetings:

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO, and Dr. Michael Sumner, CMO, will present at the 2023 Jefferies Healthcare Conference.

Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, announced the appointment of Percival Barretto-Ko to the company’s Board of Directors.

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Kristin Judge has joined as its chief growth officer, a newly created executive leadership position.